Mad Money

Lightning Round OT: Tekelec, Jazz Pharma and More

Jazz Pharmaceuticals : Cramer likes JAZZ as a speculation biotech play.

Lightning Round OT

Immunogen : Cramer is bullish on IMGN after the company’s strong showing at the recent American Society of Hematology conference.

Tekelec : TKLC is a buy, Cramer said, especially on its recent pullback. He likes it as a play on the growth in the mobile Internet space.

Call Cramer: 1-800-743-CNBC

Questions for Cramer?

Questions, comments, suggestions for the Mad Money website?